Combined antiplatelet and novel oral anticoagulant therapy after acute coronary syndrome: is three a crowd?

被引：9
作者：
Verheugt, Freek W. A. [1 ]
机构：
[1] Onze Lieve Vrouw Hosp, Dept Cardiol, Heartctr, NL-1091 AC Amsterdam, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷 / 22期
关键词：
CLOPIDOGREL; RIVAROXABAN; PRASUGREL; WARFARIN; ASPIRIN;
D O I：
10.1093/eurheartj/eht075
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1618 / 1620
页数：3
相关论文
共 15 条
  • [1] Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Management of Atrial Fibrillation and Venous Thromboembolism A Systematic Review
    Adam, Soheir S.
    McDuffie, Jennifer R.
    Ortel, Thomas L.
    Williams, John W., Jr.
    [J]. ANNALS OF INTERNAL MEDICINE, 2012, 157 (11) : 796 - +
  • [2] Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
    Alexander, John H.
    Lopes, Renato D.
    James, Stefan
    Kilaru, Rakhi
    He, Yaohua
    Mohan, Puneet
    Bhatt, Deepak L.
    Goodman, Shaun
    Verheugt, Freek W.
    Flather, Marcus
    Huber, Kurt
    Liaw, Danny
    Husted, Steen E.
    Lopez-Sendon, Jose
    De Caterina, Raffaele
    Jansky, Petr
    Darius, Harald
    Vinereanu, Dragos
    Cornel, Jan H.
    Cools, Frank
    Atar, Dan
    Luis Leiva-Pons, Jose
    Keltai, Matyas
    Ogawa, Hisao
    Pais, Prem
    Parkhomenko, Alexander
    Ruzyllo, Witold
    Diaz, Rafael
    White, Harvey
    Ruda, Mikhail
    Geraldes, Margarida
    Lawrence, Jack
    Harrington, Robert A.
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08) : 699 - 708
  • [3] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
    ALTMAN, R
    CARRERAS, L
    DIAZ, R
    FIGUEROA, E
    PAOLASSO, E
    PARODI, JC
    CADE, JF
    DONNAN, G
    EADIE, MJ
    GAVAGHAN, TP
    OSULLIVAN, EF
    PARKIN, D
    RENNY, JTG
    SILAGY, C
    VINAZZER, H
    ZEKERT, F
    ADRIAENSEN, H
    BERTRANDHARDY, JM
    BRAN, M
    DAVID, JL
    DRICOT, J
    LAVENNEPARDONGE, E
    LIMET, R
    LOWENTHAL, A
    MORIAU, M
    SCHAPIRA, S
    SMETS, P
    SYMOENS, J
    VERHAEGHE, R
    VERSTRAETE, M
    ATALLAH, A
    BARNETT, H
    BATISTA, R
    BLAKELY, J
    CAIRNS, JA
    COTE, R
    CROUCH, J
    EVANS, G
    FINDLAY, JM
    GENT, M
    LANGLOIS, Y
    LECLERC, J
    NORRIS, J
    PINEO, GF
    POWERS, PJ
    ROBERTS, R
    SCHWARTZ, L
    SICURELLA, J
    TAYLOR, W
    THEROUX, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
  • [4] Dewilde WJM, LANCET, DOI [10.1016/S0140-6736(12)62177-1, DOI 10.1016/S0140-6736(12)62177-1.PUBLISHED]
  • [5] Apixaban versus Warfarin in Patients with Atrial Fibrillation
    Granger, Christopher B.
    Alexander, John H.
    McMurray, John J. V.
    Lopes, Renato D.
    Hylek, Elaine M.
    Hanna, Michael
    Al-Khalidi, Hussein R.
    Ansell, Jack
    Atar, Dan
    Avezum, Alvaro
    Cecilia Bahit, M.
    Diaz, Rafael
    Easton, J. Donald
    Ezekowitz, Justin A.
    Flaker, Greg
    Garcia, David
    Geraldes, Margarida
    Gersh, Bernard J.
    Golitsyn, Sergey
    Goto, Shinya
    Hermosillo, Antonio G.
    Hohnloser, Stefan H.
    Horowitz, John
    Mohan, Puneet
    Jansky, Petr
    Lewis, Basil S.
    Luis Lopez-Sendon, Jose
    Pais, Prem
    Parkhomenko, Alexander
    Verheugt, Freek W. A.
    Zhu, Jun
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) : 981 - 992
  • [6] Warfarin, aspirin, or both after myocardial infarction.
    Hurlen, M
    Abdelnoor, M
    Smith, P
    Erikssen, J
    Arnesen, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) : 969 - 974
  • [7] Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
    Mega, Jessica L.
    Braunwald, Eugene
    Wiviott, Stephen D.
    Bassand, Jean-Pierre
    Bhatt, Deepak L.
    Bode, Christoph
    Burton, Paul
    Cohen, Marc
    Cook-Bruns, Nancy
    Fox, Keith A. A.
    Goto, Shinya
    Murphy, Sabina A.
    Plotnikov, Alexei N.
    Schneider, David
    Sun, Xiang
    Verheugt, Freek W. A.
    Gibson, C. Michael
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (01) : 9 - 19
  • [8] New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis
    Oldgren, Jonas
    Wallentin, Lars
    Alexander, John H.
    James, Stefan
    Jonelid, Birgitta
    Steg, Gabriel
    Sundstrom, Johan
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (22) : 1670 - 1680
  • [9] Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
    Patel, Manesh R.
    Mahaffey, Kenneth W.
    Garg, Jyotsna
    Pan, Guohua
    Singer, Daniel E.
    Hacke, Werner
    Breithardt, Guenter
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Piccini, Jonathan P.
    Becker, Richard C.
    Nessel, Christopher C.
    Paolini, John F.
    Berkowitz, Scott D.
    Fox, Keith A. A.
    Califf, Robert M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (10) : 883 - 891
  • [10] Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
    Roe, Matthew T.
    Armstrong, Paul W.
    Fox, Keith A. A.
    White, Harvey D.
    Prabhakaran, Dorairaj
    Goodman, Shaun G.
    Cornel, Jan H.
    Bhatt, Deepak L.
    Clemmensen, Peter
    Martinez, Felipe
    Ardissino, Diego
    Nicolau, Jose C.
    Boden, William E.
    Gurbel, Paul A.
    Ruzyllo, Witold
    Dalby, Anthony J.
    McGuire, Darren K.
    Leiva-Pons, Jose L.
    Parkhomenko, Alexander
    Gottlieb, Shmuel
    Topacio, Gracita O.
    Hamm, Christian
    Pavlides, Gregory
    Goudev, Assen R.
    Oto, Ali
    Tseng, Chuen-Den
    Merkely, Bela
    Gasparovic, Vladimir
    Corbalan, Ramon
    Cinteza, Mircea
    McLendon, R. Craig
    Winters, Kenneth J.
    Brown, Eileen B.
    Lokhnygina, Yuliya
    Aylward, Philip E.
    Huber, Kurt
    Hochman, Judith S.
    Ohman, E. Magnus
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (14) : 1297 - 1309
12